{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:43:23Z","timestamp":1791038603873,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,10,15]],"date-time":"2004-10-15T00:00:00Z","timestamp":1097798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,10,15]],"date-time":"2004-10-15T00:00:00Z","timestamp":1097798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1038\/sj.cgt.7700766","type":"journal-article","created":{"date-parts":[[2004,10,15]],"date-time":"2004-10-15T08:00:47Z","timestamp":1097827247000},"page":"35-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors"],"prefix":"10.1038","volume":"12","author":[{"given":"Xueying","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiquan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuting","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianning","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagat R","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey W","family":"Krissansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,10,15]]},"reference":[{"key":"BF7700766_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1096\/fasebj.8.6.7513289","volume":"8","author":"D Weinstat-Saslow","year":"1994","unstructured":"Weinstat-Saslow D, Steeg PS . Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J. 1994; 8: 401\u2013407.","journal-title":"FASEB J."},{"key":"BF7700766_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0092-8674(94)90187-2","volume":"79","author":"IJ Fidler","year":"1994","unstructured":"Fidler IJ, Ellis LM . The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 1994; 79: 185\u2013188.","journal-title":"Cell."},{"key":"BF7700766_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O'Reilly","year":"1994","unstructured":"O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994; 79: 315\u2013328.","journal-title":"Cell."},{"key":"BF7700766_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O'Reilly","year":"1997","unstructured":"O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997; 88: 277\u2013285.","journal-title":"Cell."},{"key":"BF7700766_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nm0295-149","volume":"1","author":"L Holmgren","year":"1995","unstructured":"Holmgren L, O'Reilly MS, Folkman J . Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995; 1: 149\u2013153.","journal-title":"Nat Med."},{"key":"BF7700766_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nm0696-689","volume":"2","author":"MS O'Reilly","year":"1996","unstructured":"O'Reilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996; 2: 689\u2013692.","journal-title":"Nat Med."},{"key":"BF7700766_CR7","first-page":"189","volume":"59","author":"M Dhanabal","year":"1999","unstructured":"Dhanabal M, Ramchandran R, Volk R, et al. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res. 1999; 59: 189\u2013197.","journal-title":"Cancer Res."},{"key":"BF7700766_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/7895","volume":"17","author":"P Blezinger","year":"1999","unstructured":"Blezinger P, Wang J, Gondo M, et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol. 1999; 17: 343\u2013348.","journal-title":"Nat Biotechnol."},{"key":"BF7700766_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.cgt.7700497","volume":"9","author":"T Cichon","year":"2002","unstructured":"Cichon T, Jamrozy L, Glogowska J, et al. Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: Inhibition of primary tumor growth and metastatic spread. Cancer Gene Ther. 2002; 9: 771\u2013777.","journal-title":"Cancer Gene Ther."},{"key":"BF7700766_CR10","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1073\/pnas.96.6.2811","volume":"96","author":"TL Moser","year":"1999","unstructured":"Moser TL, Stack MS, Asplin I, et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA. 1999; 96: 2811\u20132816.","journal-title":"Proc Natl Acad Sci USA."},{"key":"BF7700766_CR11","first-page":"4654","volume":"58","author":"M Kirsch","year":"1998","unstructured":"Kirsch M, Strasser J, Allender R, et al. Angiostatin suppresses malignant glioma growth in vivo. Cancer Res. 1998; 58: 4654\u20134659.","journal-title":"Cancer Res."},{"key":"BF7700766_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<694::AID-IJC12>3.0.CO;2-C","volume":"82","author":"YA Joe","year":"1999","unstructured":"Joe YA, Hong YK, Chung DS, et al. Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3. Int J Cancer. 1999; 82: 694\u2013699.","journal-title":"Int J Cancer."},{"key":"BF7700766_CR13","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1073\/pnas.95.10.5579","volume":"95","author":"L Clasesson-Welsh","year":"1998","unstructured":"Clasesson-Welsh L, Welsh M, Ito N, et al. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA. 1998; 95: 5579\u20135583.","journal-title":"Proc Natl Acad Sci USA."},{"key":"BF7700766_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000025623","volume":"36","author":"A Redlitz","year":"1999","unstructured":"Redlitz A, Daum G, Sage EH . Angiostatin diminishes activation of the mitogen-activated protein kinase ERK-1 and ERK-2 in human dermal microvascular endothelial cells. J Vasc Res. 1999; 36: 28\u201334.","journal-title":"J Vasc Res."},{"key":"BF7700766_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/sj.cgt.7700370","volume":"8","author":"X Sun","year":"2001","unstructured":"Sun X, Kanwar JR, Leung E, et al. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression. Cancer Gene Ther. 2001; 8: 719\u2013727.","journal-title":"Cancer Gene Ther."},{"key":"BF7700766_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-5793(02)02742-4","volume":"519","author":"SJ Lee","year":"2002","unstructured":"Lee SJ, Jang JW, Kim YM, et al. Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett. 2002; 519: 147\u2013152.","journal-title":"FEBS Lett."},{"key":"BF7700766_CR17","doi-asserted-by":"publisher","first-page":"27872","DOI":"10.1074\/jbc.M202771200","volume":"277","author":"YM Kim","year":"2002","unstructured":"Kim YM, Hwang S, Kim YM, et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR\/Flk-1. J Biol Chem. 2002; 277: 27872\u201327879.","journal-title":"J Biol Chem."},{"key":"BF7700766_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1083\/jcb.200203064","volume":"158","author":"J Hanai","year":"2002","unstructured":"Hanai J, Gloy J, Karumanchi SA, et al. Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol. 2002; 158: 529\u2013539.","journal-title":"J Cell Biol."},{"key":"BF7700766_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/oxfordjournals.jbchem.a003142","volume":"131","author":"T Furumatsu","year":"2002","unstructured":"Furumatsu T, Yamaguchi N, Nishida K, et al. Endostatin inhibits adhesion of endothelial cells to collagen I via alpha(2)beta(1) integrin, a possible cause of prevention of chondrosarcoma growth. J Biochem. 2002; 131: 619\u2013626.","journal-title":"J Biochem."},{"key":"BF7700766_CR20","first-page":"1944","volume":"62","author":"J Dixelius","year":"2002","unstructured":"Dixelius J, Cross M, Matsumoto T, et al. Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res. 2002; 62: 1944\u20131947.","journal-title":"Cancer Res."},{"key":"BF7700766_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1006\/mthe.2000.0243","volume":"3","author":"FA Scappaticci","year":"2001","unstructured":"Scappaticci FA, Smith R, Pathak A, et al. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice. Mol Ther. 2001; 3: 186\u2013196.","journal-title":"Mol Ther."},{"key":"BF7700766_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/A:1016067717433","volume":"4","author":"FA Scappaticci","year":"2001","unstructured":"Scappaticci FA, Contreras A, Smith R, et al. Statin-AE: a novel angiostatin-endostatin fusion protein with enhanced antiangiogenic and antitumor activity. Angiogenesis. 2001; 4: 263\u2013268.","journal-title":"Angiogenesis."},{"key":"BF7700766_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nbt0298-153","volume":"16","author":"SD Putney","year":"1998","unstructured":"Putney SD, Burke PA . Improving protein therapeutics with sustained-release formulations. Nat Biotechnol. 1998; 16: 153\u2013157.","journal-title":"Nat Biotechnol."},{"key":"BF7700766_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/7890","volume":"17","author":"RG Crystal","year":"1999","unstructured":"Crystal RG . The body as a manufacturer of endostatin. Nat Biotechnol. 1999; 17: 336\u2013337.","journal-title":"Nat Biotechnol."},{"key":"BF7700766_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/37126","volume":"390","author":"T Boehm","year":"1997","unstructured":"Boehm T, Folkman J, Browder T . Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 1997; 390: 404\u2013407.","journal-title":"Nature."},{"key":"BF7700766_CR26","doi-asserted-by":"publisher","first-page":"9064","DOI":"10.1073\/pnas.95.16.9064","volume":"95","author":"J Folkman","year":"1998","unstructured":"Folkman J . Antiangiogenic gene therapy. Proc Natl Acad Sci USA. 1998; 95: 9064\u20139066.","journal-title":"Proc Natl Acad Sci USA."},{"key":"BF7700766_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jnci\/90.4.273","volume":"90","author":"HL Kong","year":"1998","unstructured":"Kong HL, Crystal RG . Gene therapy strategies for tumor antiangiogenesis. J Natl Cancer Inst. 1998; 90: 273\u2013286.","journal-title":"J Natl Cancer Inst."},{"key":"BF7700766_CR28","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse skeletal muscle in vivo. Science. 1990; 247: 1465\u20131468.","journal-title":"Science."},{"key":"BF7700766_CR29","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/0008-5472.CAN-03-1786","volume":"64","author":"S Ponnazhagan","year":"2004","unstructured":"Ponnazhagan S, Mahendra G, Kumar S, et al. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor. Cancer Res. 2004; 64: 1781\u20131787.","journal-title":"Cancer Res."},{"key":"BF7700766_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.gt.3301874","volume":"10","author":"QL Lu","year":"2003","unstructured":"Lu QL, Bou-Gharios G, Partridge TA . Non-viral gene delivery in skeletal muscle: a protein factory. Gene Therapy. 2003; 10: 131\u2013142.","journal-title":"Gene Therapy."},{"key":"BF7700766_CR31","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1172\/JCI118573","volume":"97","author":"J Zabner","year":"1996","unstructured":"Zabner J, Ramsey BW, Meeker DP . Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest. 1996; 97: 1504\u20131511.","journal-title":"J Clin Invest."},{"key":"BF7700766_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/viro.1996.0088","volume":"217","author":"KJ Fisher","year":"1996","unstructured":"Fisher KJ, Choi H, Burda J . Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology. 1996; 217: 11\u201322.","journal-title":"Virology."},{"key":"BF7700766_CR33","first-page":"192","volume":"1","author":"S Yei","year":"1994","unstructured":"Yei S, Mittereder N, Tang K . Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Therapy. 1994; 1: 192\u2013200.","journal-title":"Gene Therapy."},{"key":"BF7700766_CR34","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/sj.gt.3300718","volume":"5","author":"JM McMahon","year":"1998","unstructured":"McMahon JM, Wells KE, Bamfo JE, et al. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle. Gene Therapy. 1998; 5: 1283\u20131290.","journal-title":"Gene Therapy."},{"key":"BF7700766_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1006\/mthe.2001.0279","volume":"3","author":"NJ Caron","year":"2001","unstructured":"Caron NJ, Torrente Y, Camirand G, et al. Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther. 2001; 3: 310\u2013318.","journal-title":"Mol Ther."},{"key":"BF7700766_CR36","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1023\/A:1018834305079","volume":"16","author":"K Anwer","year":"1999","unstructured":"Anwer K, Earle KA, Shi M, et al. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. Pharm Res. 1999; 16: 889\u2013895.","journal-title":"Pharm Res."},{"key":"BF7700766_CR37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1006\/mthe.2001.0295","volume":"3","author":"JG Fewell","year":"2001","unstructured":"Fewell JG, MacLaughlin F, Mehta V, et al. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther. 2001; 3: 574\u2013583.","journal-title":"Mol Ther."},{"key":"BF7700766_CR38","first-page":"73","volume":"23","author":"M Oga","year":"2003","unstructured":"Oga M, Takenaga K, Sato Y, et al. Inhibition of metastatic brain tumor growth by intramuscular administration of the endostatin gene. Int J Oncol. 2003; 23: 73\u201379.","journal-title":"Int J Oncol."},{"key":"BF7700766_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0168-3659(97)00215-0","volume":"52","author":"RJ Mumper","year":"1998","unstructured":"Mumper RJ, Wang J, Klakamp SL, et al. Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle. J Control Release. 1998; 52: 191\u2013203.","journal-title":"J Control Release."},{"key":"BF7700766_CR40","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/sj.gt.3301388","volume":"8","author":"X Sun","year":"2001","unstructured":"Sun X, Kanwar JR, Leung E, et al. Gene transfer of antisense hypoxia inducible factor-1\u03b1 enhances the therapeutic efficacy of cancer immunotherapy. Gene Therapy. 2001; 8: 638\u2013645.","journal-title":"Gene Therapy."},{"key":"BF7700766_CR41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.cgt.7700590","volume":"10","author":"JR Kanwar","year":"2003","unstructured":"Kanwar JR, Berg RW, Yang Y, et al. Requirements for ICAM-1 immunogene therapy of lymphoma. Cancer Gene Ther. 2003; 10: 468\u2013476.","journal-title":"Cancer Gene Ther."},{"key":"BF7700766_CR42","first-page":"5866","volume":"58","author":"A Sckell","year":"1998","unstructured":"Sckell A, Safabakhsh N, Dellian M, et al. Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice. Cancer Res. 1998; 58: 5866\u20135869.","journal-title":"Cancer Res."},{"key":"BF7700766_CR43","first-page":"5575","volume":"61","author":"M Guba","year":"2001","unstructured":"Guba M, Cernaianu G, Koehl G, et al. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res. 2001; 61: 5575\u20135579.","journal-title":"Cancer Res."},{"key":"BF7700766_CR44","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/jnci\/93.20.1541","volume":"93","author":"JR Kanwar","year":"2001","unstructured":"Kanwar JR, Shen WP, Berg R, et al. Effect of survivin antagonists on the growth of established tumors and B7.1 immunogene therapy. J Natl Cancer Inst. 2001; 93: 1541\u20131552.","journal-title":"J Natl Cancer Inst."},{"key":"BF7700766_CR45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4049\/jimmunol.156.1.73","volume":"156","author":"H Maeda","year":"1996","unstructured":"Maeda H, Shiraishi A . TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J Immunol. 1996; 156: 73\u201378.","journal-title":"J Immunol."},{"key":"BF7700766_CR46","first-page":"1273","volume":"59","author":"J Won","year":"1999","unstructured":"Won J, Kim H, Park EJ, et al. Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor \u03b2 receptor therapy. Cancer Res. 1999; 59: 1273\u20131277.","journal-title":"Cancer Res."},{"key":"BF7700766_CR47","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/sj.gt.3301016","volume":"6","author":"JR Kanwar","year":"1999","unstructured":"Kanwar JR, Berg R, Lehnert K, et al. Taking lessons from dendritic cells: multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumour immunity. Gene Therapy. 1999; 6: 1835\u20131844.","journal-title":"Gene Therapy."},{"key":"BF7700766_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1006\/mthe.2002.0572","volume":"5","author":"R Pawliuk","year":"2002","unstructured":"Pawliuk R, Bachelot T, Zurkiya O, et al. Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells. Mol Ther. 2002; 5: 345\u2013351.","journal-title":"Mol Ther."},{"key":"BF7700766_CR49","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1006\/mthe.2002.0573","volume":"5","author":"W Eisterer","year":"2002","unstructured":"Eisterer W, Jiang X, Bachelot T, et al. Unfulfilled promise of endostatin in a gene therapy\u2013xenotransplant model of human acute lymphocytic leukemia. Mol Ther. 2002; 5: 352\u2013359.","journal-title":"Mol Ther."},{"key":"BF7700766_CR50","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/bjc.1997.296","volume":"75","author":"K Hori","year":"1997","unstructured":"Hori K, Li HC, Saito S, et al. Increased growth and incidence of lymph node metastases due to the angiogenesis inhibitor AGM-1470. Br J Cancer. 1997; 75: 1730\u20131734.","journal-title":"Br J Cancer."},{"key":"BF7700766_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(03)00267-2","volume":"196","author":"J Dixelius","year":"2003","unstructured":"Dixelius J, Cross MJ, Matsumoto T . Endostatin action and intracellular signaling: beta-catenin as a potential target? Cancer Lett. 2003; 196: 1\u201312.","journal-title":"Cancer Lett."},{"key":"BF7700766_CR52","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1182\/blood.V92.10.3977","volume":"92","author":"R Lucas","year":"1998","unstructured":"Lucas R, Holmgren L, Garcia I, et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood. 1998; 92: 4730\u20134741.","journal-title":"Blood."},{"key":"BF7700766_CR53","first-page":"6511","volume":"61","author":"SA Wickstrom","year":"2002","unstructured":"Wickstrom SA, Veikkola T, Rehn M . Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res. 2002; 61: 6511\u20136516.","journal-title":"Cancer Res."},{"key":"BF7700766_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00001813-199502000-00001","volume":"6","author":"JW Rak","year":"1995","unstructured":"Rak JW, St Croix BD, Kerbel RS . Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anti-Cancer Drugs. 1995; 6: 3\u201318.","journal-title":"Anti-Cancer Drugs."},{"key":"BF7700766_CR55","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood.V95.11.3403","volume":"95","author":"J Dixelius","year":"2000","unstructured":"Dixelius J, Larsson H, Sasaki T, et al. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood. 2000; 95: 3403\u20133411.","journal-title":"Blood."},{"key":"BF7700766_CR56","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1054\/bjoc.1999.0991","volume":"82","author":"MK Oehler","year":"2000","unstructured":"Oehler MK, Bicknell R . The promise of anti-angiogenic cancer therapy. Br J Cancer. 2000; 82: 749\u2013752.","journal-title":"Br J Cancer."},{"key":"BF7700766_CR57","first-page":"2207","volume":"61","author":"K Camphausen","year":"2001","unstructured":"Camphausen K, Moses MA, Beecken WD, et al. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res. 2001; 61: 2207\u20132211.","journal-title":"Cancer Res."},{"key":"BF7700766_CR58","first-page":"6052","volume":"59","author":"W Wen","year":"1999","unstructured":"Wen W, Moses MA, Wiederschain D, et al. The generation of endostatin is mediated by elastase. Cancer Res. 1999; 59: 6052\u20136056.","journal-title":"Cancer Res."},{"key":"BF7700766_CR59","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/emboj\/19.6.1187","volume":"19","author":"U Felbor","year":"2000","unstructured":"Felbor U, Dreier L, Bryant RA, et al. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 2000; 19: 1187\u20131194.","journal-title":"EMBO J."},{"key":"BF7700766_CR60","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1126\/science.285.5435.1926","volume":"285","author":"MS O'Reilly","year":"1999","unstructured":"O'Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J . Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science. 1999; 285: 1926\u20131928.","journal-title":"Science."},{"key":"BF7700766_CR61","first-page":"7298","volume":"61","author":"O Kisker","year":"2001","unstructured":"Kisker O, Onizuka S, Banyard J, et al. Generation of multiple angiogenesis inhibitors by human pancreatic cancer. Cancer Res. 2001; 61: 7298\u20137304.","journal-title":"Cancer Res."},{"key":"BF7700766_CR62","first-page":"3308","volume":"59","author":"AL Feldman","year":"1999","unstructured":"Feldman AL, Libutti SK . Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res. 1999; 59: 3308\u20133312.","journal-title":"Cancer Res."}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7700766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700766","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T15:34:22Z","timestamp":1682782462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7700766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,15]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1,1]]}},"alternative-id":["BF7700766"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7700766","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,15]]},"assertion":[{"value":"27 March 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2004","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}